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Topic 10 – Pediatric and congenital heart
disease
0529
Infective endocarditis in patients with ventricular septal defect
Magali Veyrier, Alexandra Soufi, Mohamed Bakloul, Jean Ninet, Olivier
Metton, François Sassolas, André Bozio, Sylvie Di Filippo
Hôpital Cardiovasculaire, Cardiologie pédiatrique et congénitale, Lyon,
France
In the context of recent change in guidelines for prophylaxis of infective
endocarditis (IE), the objective of this study was to assess the features and
outcomes of IE in children and adults with non-significant ventricular septal
defect (VSD).
Methods: A retrospective analysis of records of patients with non-signifi-
cant VSD. Clinical, echocardiographic and microbiological data, and outcos
were assessed.
Results: From 1980 to 2013, 57 IE occurred (1 to 4 per year), in patients
aged 14.2±11.3y (med12.1), 29males (51%) and 39 were <18y of age. VSD
was membranous in all cases, isolated (39=68.5%) or associated with mild
aortic regurgitation or pulmonary stenosis. VSD was native in 39 (68.5%) and
not diagnosed before IE occurred in 4cases (7%). The cause of infection was
unknown in 36% of the cases, while 23% were from dental, 13% from cuta-
neous, 9% from ENT or digestive origin, and 19% occurred in the early post-
operative course of patch closure, i.e. 81% of the cases occurred in native mild
VSD. Streptococcus from dental origin was the most frequent causal agent
(54.5%), staphylococcus was found in 35% of cases, Gram-negative bacillus
in 3.5%. Hemocultures were negative in 7% of the cases. Vegetation was the
most frequent echographic lesion, and located either on VSD, and/or tricuspid
valve and/or RV free wall and/or pulmonary valve. Aortic valve location
occurred in 8cases. Embolic event occurred in 28cases (49%): multiple pulmo-
nary embolia in 21 (37%), systemic embolia in 6. Eighteen patients were oper-
ated (31.6%): early surgery in 11 (19.3%), delayed patch closure in 7. Six
patients died (10.5%). Death was not related to early surgery. FU was
13.4±11.2y (med 10.2y). 
Conclusion: Infective endocarditis impairs prognosis of mild membranous
VSD and dental events are the most frequent origin of infection. Preventive
surveillance and management of any dental lesion are probably to be empha-
sized in these patients. 
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Outcomes of pediatric hypertrophic cardiomyopathy associated with
RASopathy
Olivier Guillard, Diala Khraiche, Francesca Raimondi, Fanny Bajolle,
Pascal Vouhé, Damien Bonnet
CHU Hôpital Necker Enfants Malades-APHP, M3C, Cardiologie congéni-
tale et pédiatrique, Paris, France
Background: The outcomes of pediatric hypertrophic cardiomyopathy
(HCM) associated to RASopathies are scarcely known. 
Aim: To describe outcomes of pediatric HCM associated with RASopathy. 
Methods and results: 80 cases of children with a clinical phenotype of
RASopathy and HCM were included. Age at diagnosis of HCM was 11.7
months (range 0 to 168). The HCM was diagnosed prenatally in 9 cases, and
before one year of age in 58 cases. 67 had Noonan syndrome, 9 had Cardio-
facio-cutaneous syndrome, 3 had Costello syndrome, and 1 had Noonan syn-
drome with multiples lentigines. The HCM was obstructive in 37 cases. Asso-
ciated cardiac defects were right ventricular outflow tract obstruction in
40 children, polyvalvular dysplasia in 18, atrial septal defect (ASD) in 13,
ventricular septal defect in 3, congenital mitral regurgitation in 2, persistent
arterial duct in 2, left superior caval vein in 2, aortic arch anomaly in 2, cor-
onary anomaly in 1, and systemic arteriovenous fistula in 1. Nineteen children
underwent a Konno operation for obstructive HCM. Additional surgical pro-
cedures were 9 right ventricular outflow tract surgical reliefs, 9 percutaneous
dilatations of pulmonary valve stenosis, 4 percutaneous closures of ASD, 1 tri-
cuspid valve repair, 1 Brom procedure with aortic valve repair, 1 aortic valve
replacement, and 1 coronary artery bypass. Overall mortality was 21%. Four-
teen (82%) deaths occurred before 1 year of life. Causes of death were cardiac
in 10 cases including two sudden deaths, related to respiratory diseases causes
in 5, and in utero fœtal death in 1. Factors predicting mortality were diagnosis
before 2 months of life (HR=4,33, p<0,001), fœtal diagnosis of HCM
(HR=3,64, p<0,001), and surgery before one year of life (HR=3,43, p=0,001). 
Conclusion: Mortality of children with HCM due to RASopathy is high
and occurs early in life. Main risk factors are early diagnosis of HCM
including prenatal diagnosis, and need for surgery before one year of life. 
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3D transthoracic echocardiography to assess ventricular septal defect
anatomy and severity
Khaled Hadeed (1), Sébastien Hascoët (2), Yves Dulac (1), Romain Ama-
dieu (1), Philippe Acar (1)
(1) CHU Toulouse, Hôpital des enfants, Pediatric cardiology, Toulouse,
France – (2) CHU Toulouse, Hôpital des enfants, Pediatric cardiac sur-
gery, Toulouse, France
The pathophysiology of Ventricular Septal Defect (VSD) is determined by
the size of the defect and the state of the pulmonary vascular resistance. We
assessed the morphology of VSD using 3D transthoracic echocardiography
(3D-TTE) and the ability to estimate the pathophysiology.
Methods: We prospectively enrolled 48 children with isolated unique mus-
cular (77%) and membranous VSD (23%). Severity of the VSD was rated
according to their pathophysiology. (Type 1: minor left-to-right shunt; 2a: sig-
nificant left-to-right shunt (left ventricular end diastolic diameter (LVEDD) Z-
score >2); 2b: VSD associated with pulmonary hypertension). VSD measure-
ments were obtained after a multi-planar reconstruction of a TTE 3D full
volume (X5-1 or X7-2 matrix probes, ie33, Philips). Diagnosis properties of
the ratio of 3D-VSD area to aortic annulus area (3DA/AAA), 3D-VSD area to
body surface area (3DA/BSA) and 2Dmax diameter to BSA (2DD/BSA) were
compared.
Results: Median age was 8.5 month-old (min 1 max 123). LVEDD Zscore
was>2 in 19 children (40%), of whom 12 (25%) had pulmonary hypertension.
3D-VSD systolic area, 3D and 2D maximal diameters were correlated with
LVEDD. (r=0.71, r=0.52, r=0.55, p<0.05). Systolo-diastolic variation of 3D
VSD area was higher in muscular than in membranous VSD (Median
54%vs27%, p=0.0001). VSD were asymmetric with a mean ratio of maximal
to minimal 3D diameters of 2.1±1.3 in membranous VSD and 3.2±1.5 in mus-
cular VSD (p=0.01). VSD severity was correlated with 3DA/AAA and 3DA/
BSA ratio (r=0.63, r=0.60, p<0.05), but not with the 2DD/BSA ratio. Ability
to diagnose type 2b VSD was higher with the 3DA/AAA or 3DA/BSA ratio
than the 2D/BSA ratio (ROC area 0.97 and 0.96 vs 0.85). A 3DA/AAA
ratio>0.39 has a sensitivity of 92% and a specificity of 97% to diagnose a 2b-
VSD. 
Conclusion: 3D-TTE allows a morphological and a quantitative assess-
ment of muscular and membranous VSD. The 3DA/AAA ratio is an accurate
diagnostic tool to assess the pathophysiology of the VSD (figure next page). 
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Conservative surgery for congenital mitral valve stenosis: is it best
option?
Marianne Peyre, Lucile Houyel, Emre Belli
Centre Chirurgical Marie Lannelongue, Plessis Robinson, France
Objectives: Congenital mitral valve stenosis (CMVS) is a heterogeneous
group of lesions that can be isolated or part of left heart obstructive syndrom.
Historically, mitral valve surgery has been associated with significant mor-
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bidity and mortality. Surgical techniques have recently improved. We review
here a single-center experience in mitral valve (MV) surgery for CMVS.
Patients: Between 1975 and 2013, 50 pts underwent MV surgery for
CMVS. Six (12%) were adults (>18 yrs) and 18 were <2 yrs (36%). Median
age was 3 yrs (19 d-30 yrs, mean 6.3 yrs), median weight 13kg (2.7-80kg,
mean 19.2kg). In 35 pts, CMVS was part of left heart obstructive syndrome,
with 1 or more previous non-MV surgery in 25. Among the 15 pts with “iso-
lated” CMVS, 2 had previous non-MV surgery. Two pts had previous mitral
valvuloplasty in another center.
Results: First choice MV surgery was valvuloplasty in 48 pts, prosthetic
valve replacement (MVR) in 2. In the valvuloplasty group, 14 pts were
reoperated with a median delay of 11mo (mean 22mo, 19 d-16.6 yrs). Second
surgery was MVR in 3, valvuloplasty in 11. Five pts had a 3rd surgery
(3 MVR, 3 valvuloplasty), 2 had a 4th surgery (redo MVR). There were
6 deaths (overall mortality 12%): 2 after first surgery (1 valvuloplasty, 1
MVR, respectively 8 and 14 days postop), 4 after the second surgery (24 days
and 3.5mo after valvuloplasty, 30 days and 31 yrs after MVR). Risk factors
for postoperative death were: presence of supravalvular lesions (left superior
vena cava in the coronary sinus and/or supramitral ring, p<0.04), surgery for
supravalvular lesions (p<0.04), longer cardiac bypass time (p<0.03) and
longer ICU stay duration (p<0.01). Risk factors for reoperation were younger
age (p=0.008) and low weight (p<0.04) at first surgery. 
Conclusion: Valvuloplasty as first-choice surgery for CMVS carries an
acceptable initial mortality but a relatively high rate of reoperations (29%).
Iterative plasty is possible but mortality is higher (18%). 
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Quality of life of patients with pulmonary arterial hypertension asso-
ciated with congenital heart disease: the multicenter cross-sectional
Achille study
Pascal Amedro (1), Adeline Basquin (2), Virginie Gressin (3), Pierre
Clerson (4), Xavier Jais (5), Jean-Benoît Thambo (6), Damien Bonnet (7)
(1) CHU Arnaud de Villeneuve, Cardiologie pédiatrique et congénitale,
Montpellier, France – (2) CHU Rennes, Cardiologie pédiatrique et congé-
nitale, Rennes, France – (3) Actelion Pharmaceuticals, Paris, France –
(4) Orgamétrie, Roubaix, France – (5) CHU Hôpital Bicêtre-APHP,
Centre de Référence National HTAP, Pneumologie, Le Kremlin Bicêtre,
France – (6) CHU Bordeaux, Hôpital Haut-Lévêque, Cardiologie pédia-
trique et congénitale, Bordeaux, France – (7) CHU Hôpital Necker
Enfants Malades-APHP, M3C, Cardiologie pédiatrique et congénitale,
Paris, France
Objectives: To assess health-related quality of life (QoL) in patients with
pulmonary arterial hypertension associated with congenital heart disease
(PAH-CHD) and correlations with clinical status.
Methods: This cross-sectional study included PAH-CHD patients in 14
centers in France. QoL was self-reported with a generic questionnaire (SF-36)
and a PH-specific questionnaire (CAMPHOR). Patients filled out the Hospital
Anxiety and Depression Scale (HADS) questionnaire. Main clinical data were
collected.
Results: 200 patients were included (mean age 43±SD15.7 years, range 15
to 86 years, 70% female), and were classified as Eisenmenger syndromes
(73.5%), PAH associated with systemic to pulmonary shunts (13%), PAH
associated with small defects (3.5%) and PAH after corrective cardiac surgery
(10%). At inclusion, 76.5% patients were receiving PAH-specific treatments.
All component scores of both QoL questionnaires showed degradation vs
healthy population standard scores. QoL scores were lower in females than in
males for all dimensions of both questionnaires (p<0.05). QoL scores were
independent of the type of PAH-CHD but significantly depended on NYHA
class even after gender adjustment. In a multivariate analysis, variables signif-
icantly affecting QoL included NYHA class, six-minute walk distance,
HADS, gender, recent stressful event, and more than one hospitalization
within the past 12 months. 
Conclusion: This study showed degradation of QoL in a large cohort of
PAH-CHD patients with both generic and specific questionnaires. QoL was
correlated with NYHA class but not with the type of PAH-CHD.
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Survival advantage of Eisenmenger syndrome patients: the role of
right ventricular transverse strain
Pamela Moceri (1), Priscille Bouvier (1), Wei Li (2), Elie Dan Schouver (1),
Konstantinos Dimopoulos (2), Pierre Cerboni (1), Delphine Baudouy (1),
Pierre Gibelin (1), Michael Gatzoulis (2), Emile Ferrari (1)
(1) CHU Nice, Hôpital Pasteur, Cardiologie, Nice, France – (2) Royal
Brompton Hospital, London, Royaume-Uni
Background: Survival is improved in pulmonary arterial hypertension
(PAH) associated with congenital heart disease (CHD) patients and is related
to right ventricular (RV) function. In this study we aimed to investigate the
prognostic role of RV mechanics in Eisenmenger Syndrome (ES) compared
with other causes of PAH using speckle-tracking imaging.
Methods and Results: We performed a prospective cohort study. We
recruited 80 consecutive adult PAH patients: 39 patients with ES and non-
complex CHD (mean age 41,5±15,6 years) and 41 patients with group 1
PAH (mean age 58,9±17,8). Clinical assessment, BNP and echocardiography
were realised at the time of inclusion and then clinical outcomes were col-
lected during the regular follow-up. Normal strain values were obtained
from 37 control volunteers. On inclusion, 53 patients (66.3%) were in func-
tional class III or higher. Mean BNP was lower in ES (p<0,001) but TAPSE
(p=0,6) and peak RV longitudinal strain (p=0,9) were similar in both groups.
Global longitudinal LV strain was midly reduced in ES (–16,2±5 vs –17,9±8%,
p=0,03), whereas no difference was found for circumferential strain. Mean
RV transverse strain was higher in ES patients (27,3±17 vs 14±11%;
p<0,001) but still reduced in comparison with normal values (44,9±16%,
p<0,001). Whereas normal RVs present a base to apex transverse strain
gradient, ES patients more frequently present a predominant apical func-
tion (p<0,001). Over a median follow-up of 20,6 months, 32 patients were
hospitalized for PAH and 16 died from cardio-pulmonary causes. On
multivariate survival analysis (including age, NYHA class and advanced
therapies), peak transverse strain (HR 0.92 [0.87-0.98]) and CHD (HR
0.17 [0.05-0.6]) were associated and were the strongest predictors of
event-free survival.
Conclusion: The increased RV transverse strain and predominant apical
function in ES could explain their survival advantage as transverse strain is a
strong independent predictor of outcomes in PAH. 
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